Driverless artificial intelligence framework for the identification of malignant pleural effusion
暂无分享,去创建一个
Yuan Li | Shan Tian | Yajun Huang | Weiguo Dong | Shan Tian | W. Dong | Yuan Li | Yajun Huang
[1] N. Maskell,et al. Identification and management of pleural effusions of multiple aetiologies , 2017, Current opinion in pulmonary medicine.
[2] G. Cardoso,et al. Important prognostic factors for survival in patients with malignant pleural effusion , 2015, BMC Pulmonary Medicine.
[3] E. Mcgrath,et al. Diagnosis of pleural effusion: a systematic approach. , 2011, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[4] Carlos Luna,et al. Score for Differentiating Pleural Tuberculosis from Malignant Effusion , 2019, Medical sciences.
[5] Yangke Yu,et al. Diagnostic Accuracy of Interleukin-27 between Tuberculous Pleural Effusion and Malignant Pleural Effusion: A Meta-Analysis , 2018, Respiration.
[7] Z. Zoumot,et al. Managing malignant pleural effusion , 2019, Cleveland Clinic Journal of Medicine.
[8] K. Ho,et al. Machine learning for the prediction of volume responsiveness in patients with oliguric acute kidney injury in critical care , 2019, Critical Care.
[9] J. M. Porcel,et al. Malignant Pleural Effusions: Management Options , 2018, Seminars in Respiratory and Critical Care Medicine.
[10] Weihua Huang,et al. High Efficient Isolation of Tumor Cells by a Three Dimensional Scaffold Chip for Diagnosis of Malignant Effusions. , 2020, ACS applied bio materials.
[11] R. Light,et al. Clinical practice. Pleural effusion. , 2002, The New England journal of medicine.
[12] Daniel S. Kermany,et al. Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning , 2018, Cell.
[13] E. Alkhalili,et al. Pleural Disease. , 2018, The New England journal of medicine.
[14] N. Rahman,et al. Malignant Pleural Effusion: From Diagnostics to Therapeutics. , 2017, Clinics in chest medicine.
[15] P ? ? ? ? ? ? ? % ? ? ? ? , 1991 .
[16] J. M. Porcel,et al. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. , 2014, Archivos de bronconeumologia.
[17] Kan Zhai,et al. Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion , 2016, Chinese medical journal.
[18] Huan Wang,et al. Diagnostic value of soluble B7‐H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion , 2018, The clinical respiratory journal.
[19] Ce Zhang,et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features , 2016, Nature Communications.
[20] A. Musani,et al. Malignant pleural effusions: a review. , 2013, Clinics in chest medicine.
[21] J. M. Porcel,et al. Etiología del derrame pleural: análisis de más de 3.000 toracocentesis consecutivas , 2014 .
[22] Ziad Obermeyer,et al. Development and Application of a Machine Learning Approach to Assess Short-term Mortality Risk Among Patients With Cancer Starting Chemotherapy , 2018, JAMA network open.
[23] Jakob Nikolas Kather,et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer , 2019, Nature Medicine.
[24] N. Razavian,et al. Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning , 2018, Nature Medicine.
[25] J. M. Porcel,et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. , 2004, Chest.
[26] R. Loddenkemper. [The diagnosis of pleural effusions]. , 1992, Deutsche medizinische Wochenschrift.
[27] Yi-jian Mao,et al. Diagnosing malignant pleural effusion using clinical and analytical parameters , 2018, Journal of clinical laboratory analysis.
[28] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[29] Lijuan Hu,et al. Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion , 2017, Journal of clinical laboratory analysis.
[30] T. Jiang,et al. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion , 2019, European Journal of Nuclear Medicine and Molecular Imaging.
[31] J. M. Porcel,et al. Malignant pleural effusion: from bench to bedside , 2016, European Respiratory Review.
[32] Henry Horng-Shing Lu,et al. Accurate Classification of Diminutive Colorectal Polyps Using Computer-Aided Analysis. , 2017, Gastroenterology.
[33] P. Hahn,et al. Overfitting and Use of Mismatched Cohorts in Deep Learning Models: Preventable Design Limitations. , 2018, American journal of respiratory and critical care medicine.
[34] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[35] J. M. Porcel,et al. A decision tree for differentiating tuberculous from malignant pleural effusions. , 2008, Respiratory medicine.
[36] L. Min,et al. Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer , 2018, BMC Pulmonary Medicine.
[37] S. Bielsa,et al. Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions. , 2015, Chest.
[38] Rajarsi R. Gupta,et al. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. , 2018, Cell reports.
[39] M. P. Koster,et al. External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study , 2016, British Medical Journal.
[40] Danna Zhou,et al. d. , 1934, Microbial pathogenesis.
[41] L. Valdés,et al. Advances in pleural effusion diagnostics , 2020, Expert review of respiratory medicine.
[42] N. Maskell,et al. The modern diagnosis and management of pleural effusions , 2015, BMJ : British Medical Journal.
[43] Kyoung-Mee Kim,et al. Deep Learning–Based Survival Analysis Identified Associations Between Molecular Subtype and Optimal Adjuvant Treatment of Patients With Gastric Cancer , 2018, JCO clinical cancer informatics.
[44] Septimiu E. Salcudean,et al. A new era: artificial intelligence and machine learning in prostate cancer , 2019, Nature Reviews Urology.
[45] Fadhl M Alakwaa,et al. Deep Learning Accurately Predicts Estrogen Receptor Status in Breast Cancer Metabolomics Data , 2017, bioRxiv.
[46] H. Grosu,et al. Sensitivity of Initial Thoracentesis for Malignant Pleural Effusion Stratified by Tumor Type in Patients with Strong Evidence of Metastatic Disease , 2018, Respiration.
[47] Ling Xu,et al. Identifying tuberculous pleural effusion using artificial intelligence machine learning algorithms , 2019, Respiratory Research.
[48] K. Borgwardt,et al. Machine Learning in Medicine , 2015, Mach. Learn. under Resour. Constraints Vol. 3.
[49] Cheng Lu,et al. Nuclear shape, architecture and orientation features from H&E images are able to predict recurrence in node-negative gastric adenocarcinoma , 2019, Journal of Translational Medicine.
[50] Christoph Meinel,et al. Deep Learning for Medical Image Analysis , 2018, Journal of Pathology Informatics.